Quercetin attenuates ferroptosis-associated myocardial injury in rats after coronary microembolization by activating the Nrf۲/HO-۱ signaling pathway

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 17

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-9_005

تاریخ نمایه سازی: 17 مهر 1405

چکیده مقاله:

Objective(s): Coronary microembolization (CME) significantly contributes to the progression of heart failure and is strongly associated with adverse clinical outcomes in patients. Ferroptosis has been implicated in CME-induced myocardial injury. Quercetin has well-documented anti-inflammatory and antioxidant properties and shows therapeutic potential in coronary artery disease. However, its precise mechanism for regulating ferroptosis during CME-mediated myocardial injury remains unclear. This study aims to elucidate the therapeutic effects of quercetin and its underlying molecular mechanisms that regulate ferroptosis in cardiomyocytes following CME.Materials and Methods: The Sprague-Dawley(SD) rats were randomly divided into four groups (n=۷ each): Sham, CME, CME+Quercetin (Que), and CME+Quercetin+ML۳۸۵ (Que+ML۳۸۵). The CME model was produced by injecting microspheres into the left ventricles. We administered pharmacological treatments as follows: The Que and Que+ML۳۸۵ groups received daily oral quercetin (۲۵۰ mg/kg) starting ۷ days before model induction until the procedure day. Additionally, we pretreated the Que+ML۳۸۵ group with intraperitoneal injection of ML۳۸۵ (۳۰ mg/kg) ۲ hr before CME induction. The comprehensive evaluations include cardiac function assessment, quantification of serum biomarkers of myocardial injury, cardiac tissue histology, and analysis of ferroptosis-related molecular markers to evaluate quercetin’s therapeutic effects.Results: Quercetin pretreatment significantly improved cardiac function, reduced serum markers of myocardial injury, and decreased microinfarction size. At the molecular level, quercetin up-regulated Nrf۲ and HO-۱ expression and attenuated biochemical markers of cardiomyocyte ferroptosis. However, ML۳۸۵ co-treatment attenuated this protective effect.Conclusion: Quercetin may inhibit ferroptosis in cardiomyocytes by activating the Nrf۲/HO-۱ signaling pathway, thereby improving CME-related cardiac dysfunction and reducing myocardial injury.

نویسندگان

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

- -

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute, Nanning ۵۳۰۰۲۱, Guangxi, China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular ...
  • Scarpone M, Cenko E, Manfrini O. Coronary no-reflow phenomenon in ...
  • Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, ...
  • Kleinbongard P, Heusch G. A fresh look at coronary microembolization. ...
  • Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell ...
  • Wang H, Huang Z, Du C, Dong M. Iron dysregulation ...
  • Chen W, Zhang Y, Wang Z, Tan M, Lin J, ...
  • Wang X, Chen X, Zhou W, Men H, Bao T, ...
  • Luan X, Chen P, Miao L, Yuan X, Yu C, ...
  • Zhou Y, Long MY, Chen ZQ, Huang JW, Qin ZB, ...
  • Xie J, Mo B, Lin Y, Liu G, Nong Q, ...
  • Liu T, Shu J, Liu Y, Xie J, Li T, ...
  • Vollmannová A, Bojňanská T, Musilová J, Lidiková J, Cifrová M. ...
  • Luchkova A, Mata A, Cadenas S. Nrf۲ as a regulator ...
  • Ruan H, Zhu T, Wang T, Guo Y, Liu Y, ...
  • Zhang L, Wang X, Chang L, Ren Y, Sui M, ...
  • Ferris JA, Friesen JM. Definitions of ischaemia, infarction and necrosis. ...
  • Chen A, Chen Z, Zhou Y, Wu Y, Xia Y, ...
  • Yang T, Wu X, Wang X. HMGB۱ regulates autophagy via ...
  • Li T, Chen Z, Zhou Y, Li H, Xie J, ...
  • Li H, Yang H, Qin Z, Wang Q, Li L. ...
  • Ryabov VV, Maslov LN, Vyshlov EV, Mukhomedzyanov AV, Kilin M, ...
  • Yang C, Guo W, He R, Meng X, Fu J, ...
  • Tan M, Yin Y, Chen W, Zhang J, Jin Y, ...
  • Wu A, Zhong C, Song X, Yuan W, Tang M, ...
  • Chen G, Luo S, Guo H, Lin J, Xu S. ...
  • Shorobi FM, Nisa FY, Saha S, Chowdhury MAH, Srisuphanunt M, ...
  • Grewal AK, Singh TG, Sharma D, Sharma V, Singh M, ...
  • Onaolapo AY, Ojo FO, Onaolapo OJ. Biflavonoid quercetin protects against ...
  • Chen YF, Qiu Q, Wang L, Li XR, Zhou S, ...
  • Chang X, Zhang Q, Huang Y, Liu J, Wang Y, ...
  • Song J, Li S, Zhang B, Wu J, Zhong A. ...
  • Sun YY, Zhu HJ, Zhao RY, Zhou SY, Wang MQ, ...
  • Wu S, Zhu J, Wu G, Hu Z, Ying P, ...
  • Xue S, Chen H, Zhang J, Tian R, Xie C, ...
  • Yao D, Bao L, Wang S, Tan M, Xu Y, ...
  • Feng Q, Yang Y, Qiao Y, Zheng Y, Yu X, ...
  • Peng C, Ai Q, Zhao F, Li H, Sun Y, ...
  • He W, Su Q, Liang J, Sun Y, Wang X, ...
  • Liang J, Li L, Sun Y, He W, Wang X, ...
  • Qin Z, Kong B, Zheng J, Wang X, Li L. ...
  • نمایش کامل مراجع